Article
Novartis has pulled its TV ad for Lamisil from the air after receiving a letter from the FDA objecting to the sequence in which Novartis presents the qualifying and efficacy information for its anti-fungal.
Exploring the Effects of Masks on Skin Physiology
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Clinical Pearls for Vitiligo and Pigmentation Complexities: Part 3
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Which Tax Treatment Is Best for Your Dermatology Practice?
Facing Challenges in Pediatric Plaque Psoriasis